Danny Hart
2011
In 2011, Danny Hart earned a total compensation of $289.2K as Deputy General Counsel and Assistant Secretary at PDL BioPharma.
Compensation breakdown
| Non-Equity Incentive Plan | $39,123 |
|---|---|
| Salary | $186,300 |
| Stock Awards | $25,100 |
| Other | $38,652 |
| Total | $289,175 |
Hart received $186.3K in salary, accounting for 64% of the total pay in 2011.
Hart also received $39.1K in non-equity incentive plan, $25.1K in stock awards and $38.7K in other compensation.
Rankings
In 2011, Danny Hart's compensation ranked 9,464th out of 10,747 executives tracked by ExecPay. In other words, Hart earned more than 11.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,464 out of 10,747 | 12th |
Division Manufacturing | 3,521 out of 3,960 | 11th |
Major group Chemicals And Allied Products | 902 out of 1,033 | 13th |
Industry group Drugs | 677 out of 781 | 13th |
Industry Biological Products, Except Diagnostic Substances | 127 out of 157 | 19th |
Source: SEC filing on April 17, 2014.
Hart's colleagues
We found five more compensation records of executives who worked with Danny Hart at PDL BioPharma in 2011.
2011
Christine Larson
PDL BioPharma
Chief Financial Officer
2011
John McLaughlin
PDL BioPharma
Chief Executive Officer
2011
Christopher Stone
PDL BioPharma
General Counsel
2011
Caroline Krumel
PDL BioPharma
Former Vice President of Finance and Principal Accounting Officer
2011
Karen Wilson
PDL BioPharma